FDA Adverse Event Malfunction Summary report: N

ACCU-CHEK ® PERFORMA TEST STRIPS

MDR report key: 3910646 · Received July 2, 2014

Report

Report Number
1823260-2014-04862
Event Type
Malfunction
Date Received
July 2, 2014
Date of Event
June 5, 2014
Report Date
July 28, 2025
Manufacturer
ROCHE DIAGNOSTICS
Product Code
LFR
PMA / PMN Number
NA
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE
Health Professional
N

Narratives

Additional Manufacturer Narrative · 1

THE EVENT OCCURRED IN (B)(6). WHILE THIS PRODUCT IS NOT SOLD IN THE UNITED STATES, IT IS LIKE OR SIMILAR TO A PRODUCT MARKETED IN THE UNITED STATES.

Description of Event or Problem · 1

CUSTOMER REPORTEDLY RECEIVED THE FOLLOWING RESULTS ON THE PERFORMA SYSTEM WITHIN 10 MINUTES: 237 MG/DL, 138 MG/DL, AND 121 MG/DL. NO ACTIONS TAKEN BASED ON DEVICE RESULTS. NO ADVERSE EVENT REPORTED. REQUESTED RETURN OF SUSPECT DEVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
388591 ACCU-CHEK ® PERFORMA TEST STRIPS BLOOD GLUCOSE MONITORING TEST STRIPS LFR ROCHE DIAGNOSTICS NA 471791

Patients

Seq Age Sex Outcome Treatment
1 77 YR Male "TAORE"| "TIMOCOL"| AMLODIPINE| ATENOLOL| COVERSYL| LANTUS| NOVORAPID| PLAVIX| "TIMOCOL"| ATENOLOL| LANTUS| AMLODIPINE| NOVORAPID| "TAORE"| COVERSYL| PLAVIX